|1.||Holmdahl, Rikard: 25 articles (03/2015 - 01/2002)|
|2.||Reeves, Westley H: 16 articles (01/2015 - 08/2002)|
|3.||Gulko, Pércio S: 14 articles (01/2015 - 08/2002)|
|4.||Olofsson, Peter: 13 articles (09/2008 - 01/2002)|
|5.||Lu, Shemin: 12 articles (02/2015 - 08/2002)|
|6.||Satoh, Minoru: 11 articles (04/2012 - 08/2002)|
|7.||Laragione, Teresina: 9 articles (01/2015 - 07/2007)|
|8.||Brenner, Max: 9 articles (07/2013 - 01/2005)|
|9.||Xu, Yuan: 7 articles (01/2015 - 11/2009)|
|10.||Lee, Pui Y: 7 articles (04/2013 - 12/2008)|
01/01/2014 - "The objective of this study is to construct and identify an inducible lentiviral vector containing improved tet-on system and FasL gene and observe its effects on pristane-induced arthritis (PIA). "
04/01/2012 - "In this study, we used Illumina RatRef-12 microarrays to analyze the expression of 21,922 genes in synovial tissues from arthritis-susceptible DA and arthritis-protected DA.ACI(Cia10) congenics with pristane-induced arthritis. "
04/01/2012 - "The aim of this study is to investigate the regulation and potential role of TLR2 in spleen of pristane-induced arthritis (PIA) rat, which can be used to further understand the mechanisms of RA. "
01/01/2010 - "The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis. "
08/01/2015 - "Arthritis developed within two weeks after a single pristane injection. "
01/01/2001 - "Concomitantly, resistant C57BL/6 mice, from which both gene products of the Cdkn2a gene have been eliminated, developed pristane-induced plasma cell tumors over a shorter latency period than the traditionally susceptible BALB/cAn strain. "
10/01/2009 - "Our study was initiated to identify the modifier gene(s) encoded by the Pctm locus, in which mouse B-cell plasmacytomas induced by pristane are associated with heterozygosity of Chr 1 genes near the Ifi200 cluster. "
01/01/1990 - "The studies showed that APECs from mice exposed to treatment with pristane were able to stimulate growth of both TEPC-15f and MP-26 plasmacytoma. "
03/01/2009 - "Here we review these advances and discuss the usage of pristane-induced mouse plasmacytomas as a tool to investigate the origin of Igh-cMyc translocations and B-cell tumorigenesis."
03/15/2007 - "Plasmablastic plasmacytomas from NFS.V(+) and SJL-beta2M(-/-) mice did not have structural alterations in Myc or T(12;15) translocations and did not express Myc at high levels, regular features of transgenic and pristane-induced plasmacytomas. "
06/01/1995 - "The purpose of this study was to estimate the disposition of an amount of intraperitoneally injected pristane that would conventionally be used in a tumor induction protocol. "
07/15/1988 - "This study demonstrates that an inflammatory response caused by the injection of pristane into the peritoneal cavity of mice provides a useful system for rapid induction of myeloid tumors by retroviruses. "
11/26/2007 - "We asked if AID is required for accelerated tumor development in pristane-treated Bcl-xL transgenic BALB/c mice deficient in AID (pBxAicda-/-). "
06/01/2005 - "These results indicate a direct anti-tumor effect of ZOL in pristane-induced PCT development BALB/c mice, which may contribute to their significantly increased survival. "
04/01/2005 - "This pristane-mediated effect clearly could be a contributing factor in the chemical carcinogenesis of the previously observed lymphoid malignancies, and a possible basis for the tumor enhancing effects of pristane."
|4.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/01/2011 - "[Study on experimental systemic lupus erythematosus mouse model induced by pristane]."
11/15/2014 - "Collectively, Mac-1 promoted acute inflammatory responses in the peritoneal cavity and the lungs by downregulating granulocyte migration and subsequent phenotypic conversion of macrophages in a pristane-induced systemic lupus erythematosus model. "
11/01/2011 - "An intraperitoneal innate immune reaction to pristane is primarily accountable for the development of the systemic lupus erythematosus-like disease in the model. "
10/01/2005 - "These findings suggest that apoptosis may be a critical initial event in the pathogenesis of pristane-induced lupus and are of potential relevance for human systemic lupus erythematosus."
02/01/2011 - "To establish the systemic lupus erythematosus (SLE) mouse model through pristane intraperitoneal injection and discuss the pathogenesis of SLE in this mouse model. "
11/01/1996 - "We present a novel animal model for rheumatoid arthritis induced with a well defined synthetic adjuvant oil, pristane. "
07/02/2013 - "Cia4 is a locus on rat chromosome 7 that regulates disease severity and joint damage in models of rheumatoid arthritis, including pristane-induced arthritis (PIA). "
07/01/2013 - "Pristane-induced lupus (PIL) can be induced in various mouse strains such as BALB/c and C57BL/6. We herein characterize clinical and histological features of arthritis in the context of systemic lupus and provide a prudent comparison with models of rheumatoid arthritis (RA). "
09/01/2010 - "The invasive properties of fibroblast-like synoviocytes (FLS) correlate with radiographic and histologic damage in rheumatoid arthritis (RA) and pristane-induced arthritis (PIA). "
01/01/2010 - "Pristane-induced arthritis (PIA) in the rat has been described as an animal model of inflammatory arthritis which exhibits features similar to rheumatoid arthritis in humans, such as a chronic, destructive, and symmetrical involvement of peripheral joints. "
|1.||Heat-Shock Proteins (Heat-Shock Protein)
|2.||Interleukin-6 (Interleukin 6)
|7.||Toll-Like Receptor 3
|9.||Interleukin-17 (Interleukin 27)
|3.||Transplantation (Transplant Recipients)